Mawdsleys is delighted to announce a new solus hospital distribution agreement with M&A Pharmachem.   From 1st July 2014, Mawdsleys  will become the sole distributor for all M&A Pharmachem contracted products into the hospital sector, which previously hospitals purchased from M&A directly.   As from this date, all orders for M&A products…

  We are extremely proud of our patient-centric unrivalled service at Mawdsleys.   Over a recent bank holiday, our unlicensed team received an urgent, time-sensitive order request from a leading NHS children’s hospital in the North West to secure compassionate access to a medicine on clinical trial in North America…